Article
Thymosin alpha 1 exerts beneficial extrapulmonary effects in cystic fibrosis.
European journal of medicinal chemistry - 1 Jan 2021
Bellet Marina M, Borghi Monica, Pariano Marilena, Renga Giorgia, Stincardini Claudia, D'Onofrio Fiorella, Brancorsini Stefano, Garaci Enrico, Costantini Claudio, Romani Luigina
Abstract excerpt
Cystic fibrosis (CF) is an autosomal recessive disorder caused by mutations in the gene encoding for the ion channel Cystic Fibrosis Transmembrane conductance Regulator (CFTR). Long considered a lung disease for the devastating impact on the respiratory function, the recent diagnostic and therapeutic advances have shed the light on the extra-pulmonary manifestations of CF, including gastrointestinal,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
